Transdermal Estrogen

Transdermal estrogen is estradiol delivered through the skin, as a patch, gel, or cream. It enters the bloodstream directly. It does not pass through the liver first. It therefore avoids first-pass liver metabolism, the breakdown of a drug by the liver before it reaches the rest of the body. Estrogen taken by mouth works differently. It reaches the liver first, and the liver converts much of it into estrone, a weaker estrogen. Delivery through the skin keeps the balance between estradiol and estrone closer to the balance a woman's body produces before menopause.

Because the liver does not receive the same load, skin delivery has less effect on clotting factors. It also has less effect on C-reactive protein, a marker of inflammation.1 In one six-month comparison, estrogen taken by mouth raised triglycerides, a type of blood fat. Estradiol gel on the skin did not.2 These differences matter for women with a higher risk of blood clots, metabolic concerns, or cardiovascular risk.

Transdermal estrogen is one way to deliver estrogen in hormone replacement therapy for menopause or premature ovarian insufficiency. Other routes exist. The route, the form, and the length of treatment depend on the woman. Her risk profile, the reason for treatment, and her own response all guide the choice. Dose belongs in that conversation with her clinician, not in a general definition.

Estrogen has a smaller role in restorative care outside of menopause. Low estrogen can leave cervical mucus thin or scant. Healthy mucus helps sperm survive and reach the egg. A clinician may find a poor cervical mucus pattern with low estrogen behind it. Targeted estrogen support is one option in that case. It requires a clear reason to begin and ongoing monitoring of her hormonal response. The choice of route is part of that clinical decision.

Restorative care looks for the cause of the symptoms before turning to hormone replacement. Evaluation comes first. It covers the whole picture, including nutrition and daily habits. Transdermal estrogen, when a clinician uses it, is one tool that follows that work.

Cited in this entry

  1. Kopper NW, Gudeman J, Thompson DJ. Transdermal hormone therapy in postmenopausal women: a review of metabolic effects and drug delivery technologies. Drug Des Devel Ther. 2009. Drug Design, Development and Therapy. https://pmc.ncbi.nlm.nih.gov/articles/PMC2761184/
  2. Karjalainen A, Heikkinen J, Savolainen MJ, et al. Metabolic changes induced by peroral oestrogen and transdermal oestradiol gel therapy. British Journal of Obstetrics and Gynaecology. 1997;104(Suppl 16):38-43. British Journal of Obstetrics and Gynaecology. https://pubmed.ncbi.nlm.nih.gov/9389782/

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.